Stephen Brannan
Corporate Officer/Principal at American College of Neuropsychopharmacology
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Christophe Weber | M | 57 | 10 years | |
| Andrew Plump | M | 58 | 9 years | |
| Constantine Saroukos | M | 53 | 9 years | |
| Jason Brown | M | 37 | 6 years | |
| Amir Kalali | M | 58 |
International Society for CNS Drug Development
Cns Summit
| - |
| Mark Demitrack | M | 66 |
American College of Neuropsychopharmacology
 American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | - |
| Srinivas Rao | M | 55 |
American College of Neuropsychopharmacology
American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | - |
| Steven E. Hyman | M | 71 |
American College of Neuropsychopharmacology
American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | 6 years |
| Michael Mendelsohn | M | 69 | 9 years | |
| Mwana Lugogo | M | 54 | 12 years | |
| Bankole Johnson | M | 64 |
American College of Neuropsychopharmacology
American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | 25 years |
| Raymond Sanchez | M | 63 |
International Society for CNS Drug Development
| - |
| Christopher O'Reilly | M | - | 13 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Andrew Miller | M | 42 | 15 years | |
| Eric Elenko | M | 51 | 10 years | |
| Steven Paul | M | 73 | 6 years | |
| Deborah Dunsire | M | 61 |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | 6 years |
| Atul Pande | M | 69 | 8 years | |
| Christopher Coughlin | M | 71 | 4 years | |
| Shiro Kuniya | M | 67 | - | |
| Iwaaki Taniguchi | M | - | - | |
| William Meury | M | 56 | 1 years | |
| Mia Kelley | F | - | 4 years | |
| Gerhard Koenig | M | 63 |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | 13 years |
| François-Xavier Roger | M | 61 | 2 years | |
| Fumio Sudo | M | 83 | 6 years | |
| Frank Morich | M | 69 | 4 years | |
| David Wheadon | M | 66 | 4 years | |
| Denice Torres | F | 64 | 4 years | |
| Heather Elizabeth Preston | M | 58 | 2 years | |
| Masahiro Sakane | M | 83 | - | |
| Yorihiko Kojima | M | 82 | - | |
| Tadataka Yamada | M | 77 | 4 years | |
| James Healy | M | 58 | 5 years | |
| Robert Nelsen | M | 60 | 3 years | |
| Laurie Olson | F | 61 | 4 years | |
| Edmund Harrigan | M | 71 | 9 years | |
| Karen Brennan | F | 68 |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | 3 years |
| Jamie Dananberg | M | 66 | 3 years | |
| Michael W. Stevenson | M | - |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | 2 years |
| Sigurd Okkels | M | - | 6 years | |
| Azmi Nabulsi | M | 64 | 4 years | |
| Charmaine Lykins | F | 54 | 2 years | |
| Timothy Sullivan | M | 54 | 3 years | |
| Jessica Sachs | M | 49 | 5 years | |
| Jeff Jonas | M | 71 | 6 years | |
| Tom Harris | M | - | 7 years | |
| Gregory T. Brophy | M | - | - | |
| Inder Kaul | M | - | - | |
| Alexis Smith | F | - | 1 years | |
| Claudio Dansky Ullmann | M | - | 3 years | |
| Quentin McCubbin | M | 54 | 7 years | |
| Gregg A. Pratt | M | - | - | |
| Yan Zhu | M | 60 | 2 years | |
| Elena Cant | F | 47 | 7 years | |
| Bob Josefsberg | M | - | - | |
| George Apostol | M | 51 | - | |
| Karen Ferrante | M | 66 | 6 years | |
| Asit Parikh | M | 52 | 7 years | |
| James E. Audia | M | 68 | 5 years | |
| Bharatt Chowrira | M | 59 | 2 years | |
| Ben Shapiro | M | 84 | - | |
| Anna Protopapas | F | 59 | 4 years | |
| William Kane | M | 62 | 1 years | |
| Troy Ignelzi | M | 56 | 4 years | |
| Joep Muijrers | M | 51 | 1 years | |
| Stephen M. Muniz | M | - | - | |
| Michael Martin | M | 50 | 3 years | |
| Hiromichi Kimura | M | 73 | 7 years | |
| Trevor Smith | M | - | - | |
| Ralf Clemens | M | 71 | 3 years | |
| Jostein Davidsen | M | 65 | 3 years | |
| Robert Dolski | M | 54 |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | 3 years |
| Yoshiaki Nomura | M | - | - | |
| Tetsuo Miwa | M | - | - | |
| Christine A. Carberry | F | 63 |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | 4 years |
| Maiken Keson-Brookes | F | 52 |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | 6 years |
| Futoshi Sanematsu | M | - | - | |
| Satoshi Adachi | M | - | - | |
| Ronald Marcus | M | 65 | 3 years | |
| Jonathan Rosin | M | - | 1 years | |
| An Bang Lu | M | 58 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 44 | 53.66% |
| Japan | 39 | 47.56% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stephen Brannan
- Personal Network
